Seroprevalence of Human Granulocytic Ehrlichiosis Among Permanent Residents of Northwestern Wisconsin
Author(s) -
Johan Bakken,
Paul Goellner,
Mark Van Etten,
D. Boyle,
Oscar L. Swonger,
Sonja Mattson,
J. Krueth,
Robert L. Tilden,
Kristin M. Asanovich,
Jennifer J. Walls,
J. Stephen Dumler
Publication year - 1998
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/515048
Subject(s) - ehrlichiosis , seroprevalence , medicine , subclinical infection , ehrlichia , immunology , titer , rickettsiosis , tick , tick borne disease , antibody , antibody titer , serology , veterinary medicine , virology
Four-hundred seventy-five permanent residents of Wisconsin were tested for antibodies to the agent of human granulocytic ehrlichiosis (HGE) by indirect immunofluorescent antibody (IFA) testing with Ehrlichia equi as antigen marker. Each resident completed a standard survey questionnaire about outdoor activities, animal and tick exposure, and any febrile illness during the preceding 12 months. Seventy-one serum samples (14.9%) contained E. equi antibodies. The mean IFA titer for seropositive residents was 250 (range, 80-10,240). Seropositive residents were older than seronegative ones (62 vs. 56 years; P = .019). None of the seropositive residents had a history suggestive of ehrlichiosis. There was no association between the IFA test outcome and specific demographic variables or history of tick bites. HGE appears to be a common subclinical or mild infection among residents in northwestern Wisconsin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom